LEVO Health

JUNE 14, 2024

The healthcare industry – along with the rest of the modern world – is witnessing a transformative shift with the integration of artificial intelligence (AI), reshaping the way providers interact with and care for patients. Enhanced Diagnostic Accuracy AI algorithms are increasingly used to assist in the accurate diagnosis of diseases.

Healthcare 52

Healthcare Healthcare Patients Healthcare Provider 52

Healthcare Success

OCTOBER 17, 2024

Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.

Healthcare 113

Healthcare Healthcare Patients Insurance 113

Silver Line CRM

NOVEMBER 11, 2020

Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. .

Marketing 52

Marketing Pharmaceutical Side effects Insurance 52

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. New hope for stomach cancer patients.

Patients 104

Patients Food and Drug Administration Side effects Safety 104

World of DTC Marketing

DECEMBER 28, 2020

As we look forward to 2021 DTC marketers should be noting the changes in consumer attitudes and the way they request new treatments. Yes, telehealth has grown substantially, but that’s because patients are afraid of going into doctor’s offices. Much has changed but a lot is also the same. Some are, but most aren’t.

Doctors 296

Doctors Side effects Marketing Patients 296

Pharmaceutical Technology

NOVEMBER 14, 2022

In September, a group from Friedrich Alexander University Erlangen-Nuremberg reported that five patients with lupus achieved remission after an infusion of autologous chimeric antigen receptor (CAR)-T cells led to a deep depletion of B cells. All five patients achieved remission after three months. MSCs and CAR-Ts for lupus.

Side effects 144

Side effects Patients Manufacturing Safety 144

Pharma Marketing Network

MAY 3, 2023

Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information. References: 1.

Safety 52

Safety Food and Drug Administration Pharmaceutical Marketing 52

European Pharmaceutical Review

APRIL 20, 2023

“These results are exciting… this treatment led to fewer days with migraine for people who had already tried up to four other types of drugs to prevent migraine and either had no improvement or had side effects that outweighed any benefits,” commented study author Dr Patricia Pozo-Rosich, PhD at Vall d’Hebron University Hospital in Barcelona, Spain.

Side effects 98

Side effects Safety Medical Pharmaceutical 98

European Pharmaceutical Review

OCTOBER 7, 2022

Slow-release formulations were a popular choice for manufacturers, as these varieties reduce the traditional dosage frequency for patients, who only need to take these medications say, once a week. This is especially beneficial as a way of decreasing potential side effects.

Manufacturing 98

Manufacturing Marketing Side effects Transportation 98

European Pharmaceutical Review

OCTOBER 10, 2022

percent of whooping cough cases in 2021 were those six months or younger. The FDA initially approved Boostrix in 2005 as a vaccine to protect against Tdap in patients from 10 years old to 18. The US Centres for Disease Control and Prevention (CDC) estimate that 4.2

FDA 105

FDA Food and Drug Administration Side effects Food 105

Clarivate

AUGUST 17, 2022

In our latest podcast, Ideas to Innovation, we speak with Dr. Grace Lomax, the clinical director at Patient Connect, part of Clarivate. In 2017, the same year the SDGs came into effect, the United Nations found that less than half of the global population was covered by essential health services. Dr. Grace Lomax.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

PM360

MAY 25, 2023

adults experienced mental illness in 2021, which represents about 1 in 5 adults or 57.8 Through real-world data studies, we have longer horizons to look at prescribing patterns and to see what’s happening with patients over time. They’re wonderful medications, blockbuster sales, but real side effects. million people.

Side effects 95

Side effects Medical Patients Networking 95

pharmaphorum

NOVEMBER 16, 2022

The study of GSK3036656 – an inhibitor of the bacterial enzyme leucyl t-RNA synthetase (LeuRS) – showed that 14 days’ treatment with a low once-daily dose showed it was able to kill Mycobacterium tuberculosis in patients with drug-susceptible pulmonary tuberculosis , with no serious adverse effects. An estimated 10.6

Side effects 94

Side effects Healthcare Healthcare Patients 94

pharmaphorum

JANUARY 3, 2023

The Italian biopharma said it had decided to press ahead with the new study after assessing results from 100 patients with TRS in open-label studies who received the glutamate modulator drug as an add-on to their current therapy for more than six months. in the evenamide group.

Side effects 104

Side effects Biopharma Patients Competition 104

Pharmaceutical Technology

JUNE 12, 2023

A US Food and Drug Administration (FDA) Advisory Committee (AdCom) has unanimously voted in support of Eisai and Biogen’s Leqembi and its clinical benefit in patients with early Alzheimer’s disease , raising the drug’s full approval prospects. The trial reported a statistically significant reduction of clinical decline in the patients.

Food and Drug Administration 52

Food and Drug Administration Side effects Prospecting FDA 52

European Pharmaceutical Review

JUNE 12, 2024

This randomised, open label-controlled multicentre clinical trial was conducted across 21 sites in Spain from 2021 to 2023. The study included 92 adult patients with confirmed CDI. After treatment, patients were followed up at intervals of 72 hours, three weeks, eight weeks, three months and six months. 2021; 27 (2): S1-S21.

Safety 111

Safety Side effects Patients Healthcare 111

LEVO Health

JULY 15, 2024

In 2021, the GLP-1 market was valued at $16.53 To stand out in this competitive landscape, businesses must focus on patient engagement, comprehensive service offerings, strong marketing and branding, and strategic partnerships with top-tier telehealth service providers like WellSync and medical marketing experts like Levo Health.

Marketing 52

Marketing Side effects Education Medical 52

Pharmaceutical Technology

APRIL 21, 2023

The US Food and Drug Administration granted approval to Entadfi for the treatment of BPH in December 2021. Our core mission of helping patients in need remains strong and steadfast, and we look forward to developing this asset and our pipeline for patients around the world.”

Food and Drug Administration 52

Food and Drug Administration Side effects Distribution Sales 52

pharmaphorum

SEPTEMBER 7, 2022

The FDA had approved the drug for use as UC treatment in the US in May 2021. Given the unpredictability of when flare-ups occur, UC patients often exhibit symptoms of stress and anxiety as well, negatively impacting their daily lives overall. A lifelong condition, UC results in inflamed and ulcerated rectal and colonic lining.

Side effects 52

Side effects Patients FDA Medical 52

pharmaphorum

JULY 19, 2022

Steroids can be used to slow down progression of the condition, but can cause significant side effects if used too much and do nothing to restore the usual skin colour. The company is gunning for sales in atopic dermatitis alone of $1.5 The post FDA clears Incyte’s Opzelura as first vitiligo therapy appeared first on.

FDA 94

FDA Side effects Sales Safety 94

PM360

OCTOBER 24, 2022

While Urovant realized this, launching a new company, a new sales team, and a new therapy for OAB amidst the pandemic in early 2021 would be challenging. Extensive quantitative and qualitative research prioritized the most effective messaging with patients and with HCPs to develop an optimal story flow.

Side effects 40

Side effects Doctors FDA Patients 40

PM360

AUGUST 9, 2022

Medication non-adherence has a staggering impact on the industry’s ability to serve patient well-being and achieve growth. A patient is diagnosed and prescribed a treatment to correct or mitigate a condition. However, most patients have very little time with their physician to learn all aspects of their prescribed medication.

Education 59

Education Side effects Physicians Patients 59

Pharmaceutical Technology

MAY 26, 2023

The FDA first granted the drug under an emergency use authorisation (EUA) during the pandemic in December 2021. However, upon Paxlovid’s widespread use, some patients reached full recovery from Covid-19 only to test positive again or have a relapse in symptoms within a few days or weeks. Paxlovid’s most common side effect is diarrhoea.

Food and Drug Administration 59

Food and Drug Administration FDA Side effects Safety 59

Pharmaceutical Technology

JULY 20, 2022

The nonprofit Physicians for Patient Protection also raised a similar point that pharmacists who may be unfamiliar with a patient’s medical history can pose the risk of significant negative health outcomes if Paxlovid is incorrectly prescribed. This is where pharmacists can make a difference, he notes.

Food and Drug Administration 111

Food and Drug Administration Physicians Medical Prescription 111

pharmaphorum

OCTOBER 27, 2022

The phase 3 clinical programme, named ContRAst, was the first in RA to include head-to-head comparisons of otilimab with current treatments, hoping to build a niche for otilimab among hard-to-treat patients who have an inadequate response to or cannot tolerate available drugs.

Side effects 78

Side effects FDA Patients Sales 78

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. from 2021 and reach $4.2 But it is not a simple answer. billion in 2025.

Prescription 105

Prescription Medical Patients Side effects 105

Impetus Digital

AUGUST 2, 2024

From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal side effects. The pharmaceutical industry has numerous use cases for AI.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

pharmaphorum

JANUARY 26, 2023

Merck has said it will abandon the KEYNOTE-991 study of PD-1 inhibitor Keytruda (pembrolizumab) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) after it showed no benefit on either overall survival (OS) or radiographic progression-free survival (rPFS) when the data was analysed midway though.

Side effects 59

Side effects Patients FDA 59

pharmaphorum

DECEMBER 13, 2022

Krazati has been cleared as a treatment for patients with KRASG12C-mutated non-small cell lung cancer (NSCLC) after one prior systemic therapy – the same indication given to Amgen’s Lumakras (sotorasib) when it became the first KRAS inhibitor to be approved in the US in May 2021.

FDA 52

FDA Side effects Competition Patients 52

European Pharmaceutical Review

OCTOBER 19, 2023

These diagnostics have significantly progressed based on rigorous Phase III trial designs and because of the impact these diagnostics have had on patient management. These diagnostics are also paired with therapeutics and act as an imaging biomarker to identify patients who may benefit from the paired therapies.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Side effects Doctors 105

pharmaphorum

JULY 19, 2022

China’s Simcere Pharmaceutical has been granted approval in its home market for Cosela, a drug designed to limit the side effects of cancer chemotherapy, partnered with US biotech G1 Therapeutics. It is also being tested in phase 3 trials involving patients with advanced colorectal cancer and triple-negative breast cancer (TNBC).

Side effects 59

Side effects Marketing Pharmaceutical Patients 59

European Pharmaceutical Review

NOVEMBER 4, 2022

tumour effects. Nevertheless, chemotherapy’s disadvantages, including substantial toxicities, combined with inconvenient hospital-based intravenous (IV) administration, impede patients’ ability to stay on treatment and their quality of life. The importance of taxanes in oncology.

Food and Drug Administration 98

Food and Drug Administration Pharmaceutical FDA Patients 98

PM360

AUGUST 26, 2024

Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. By sequencing the genomes of over 1,000 patients, they have identified 20 new ultra-rare genetic conditions. As of 2021, 537 million adults were living with diabetes worldwide.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharmaceutical Technology

APRIL 13, 2023

Many of the GLP-1RAs are used off-label and are mainly indicated for patients with type 2 diabetes (T2D). Improved awareness of the risks of obesity and disease progression may also help improve access to resources and treatment available for patients with obesity.

Marketing 52

Marketing Side effects Physicians Management 52

Pharmaceutical Technology

AUGUST 17, 2022

In September 2021, the same study reported a 100% seroconversion rate after a booster was given to the participants. In a separate Phase II VLA15-221 study, which looked at adult and pediatric patients, the vaccine had stronger immunogenicity in children than in adults. No serious vaccine-related adverse events were reported.

Side effects 119

Side effects Medicine Marketing Recruitment 119

PM360

JULY 13, 2023

Here are twelve of the best examples of programs, strategies, solutions, technology, and more that companies have developed or are using to keep patients on their prescribed therapies. But outdated manual processes are complex and leave many patients out. But outdated manual processes are complex and leave many patients out.

Education 89

Education Medical Patients Media 89